InMed Pharmaceuticals, Inc.

Latest

May 15, 2019, 07:25 ET InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

VANCOUVER, May 15, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for...


May 08, 2019, 07:25 ET InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019

TSX:IN OTCQX:IMLFF VANCOUVER, BC, May 8, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis...


Mar 18, 2019, 07:25 ET InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology

TSX: IN OTCQX: IMLFF VANCOUVER, March 18, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis...


Mar 13, 2019, 07:25 ET InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate - INM-755 - for its Epidermolysis Bullosa Program

Transition to INM-755 Expected to Improve the Probability of Development and Regulatory Success Initiation of a Phase I Clinical Trial Remains On-track TSX:IN OTCQX:IMLFF VANCOUVER, March 13, 2019...


Mar 12, 2019, 07:25 ET InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019

TSX:IN OTCQX:IMLFF VANCOUVER, March 12, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis...


Mar 06, 2019, 07:25 ET InMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board

TSX:IN OTCQX:IMLFF Dinh Fortifies InMed's Development Expertise in Dermatology and Drug Delivery VANCOUVER, March 6, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN;...


Feb 12, 2019, 07:25 ET InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

TSX:IN OTCQX:IMLFF VANCOUVER, Feb. 12, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that...


Feb 05, 2019, 07:25 ET InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019

TSX:IN OTCQX:IMLFF VANCOUVER, Feb. 5, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that ...


Jan 11, 2019, 07:25 ET InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as

TSX:IN OTCQX:IMLFF VANCOUVER, Jan. 11, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that...


Jan 03, 2019, 10:25 ET InMed Pharmaceuticals to Present at Biotech Showcase 2019 on January 9, 2019

TSX:IN OTCQX:IMLFF VANCOUVER, Jan. 3, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX : IN) (OTCQX : IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company...


Dec 04, 2018, 07:25 ET InMed Pharmaceuticals Receives Funding from the Government of Canada to Support Development of Novel Cannabinoid Biosynthesis Program

TSX:IN OTCQX:IMLFF VANCOUVER, Dec. 4, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a cannabinoid-based biopharmaceutical company that leverages its...


Nov 12, 2018, 07:25 ET InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

TSX:IN OTCQX:IMLFF VANCOUVER, Nov. 12, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that...


Nov 05, 2018, 07:25 ET InMed Pharmaceuticals to Report First Quarter Fiscal 2019 Financial Results and Business Update on November 12, 2018

TSX:IN OTCQX:IMLFF VANCOUVER, Nov. 5, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that...


Nov 05, 2018, 07:20 ET InMed Pharmaceuticals Appoints Michael Woudenberg as Vice President, Chemistry, Manufacturing, and Controls

TSX:IN OTCQX:IMLFF VANCOUVER, Nov. 5, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a cannabinoid-based biopharmaceutical company that leverages its...


Oct 10, 2018, 07:25 ET InMed Pharmaceuticals to Present at BIO Investor Forum on October 17, 2018

TSX: IN OTCQX: IMLFF VANCOUVER, Oct. 10, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company...


Oct 03, 2018, 07:25 ET InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada for Cannabinoid Biofermentation Process Development and Scale-Up

TSX:IN OTCQX:IMLFF VANCOUVER, Oct. 3, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a cannabinoid-based biopharmaceutical company that leverages its...


Sep 25, 2018, 07:25 ET InMed Pharmaceuticals Files PCT Patent Application for the Treatment of Pain with Cannabinoids

VANCOUVER, Sept. 25, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its...


Sep 13, 2018, 07:25 ET InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update

VANCOUVER, Sept. 13, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its...


Sep 11, 2018, 07:25 ET InMed Pharmaceuticals Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work

VANCOUVER, Sept. 11, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its...


Sep 10, 2018, 07:25 ET InMed Files Patent Application for its Cannabinoid Biosynthesis Program

TSX:IN OTCQX:IMLFF VANCOUVER, Sept. 10, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that...


Sep 07, 2018, 07:25 ET InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2018 Financial Results and Business Update on September 13, 2018

VANCOUVER, Sept. 7, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its...


Aug 31, 2018, 07:25 ET InMed Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference

TSX:IN OTCQX:IMLFF VANCOUVER, Aug. 31, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that...


Aug 01, 2018, 07:25 ET InMed to Present at the Canaccord Genuity 38th Annual Growth Conference

VANCOUVER, Aug. 1, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its...


Jun 21, 2018, 11:13 ET InMed Pharmaceuticals Announces the Closing of C$14.95 Million Bought Deal Financing including Full Exercise of Underwriter's Over-Allotment Option

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, June 21, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN;...


May 29, 2018, 07:25 ET InMed to Present at the 8th Annual LD Micro Invitational Conference

VANCOUVER, May 29, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its...